As the global Covid-19 toll mounts, with 6494 deaths so far, how close are new drugs to treat the disease?
Point of Order has been searching international media for news of the work of much-criticised Big Pharma and found at least 11 companies engaged in developing anti-viral drugs to be used in treatment against the disease.
The most advanced of these appears to be California-based Gilead Sciences, which for the past few years has been developing Remdesivir, an anti-viral with promising results in lab and animal studies against SARS, MERS, Ebola and other infectious diseases, including Covid-19.
Remdesivir is already being tested in Wuhan, the centre of the epidemic, and the US National Institute of Health has indicated the drug would also be studied in some of the patients who contracted the illness overseas and are now being treated in the US.
View original post 1,311 more words
Utopia, you are standing in it! 
Recent Comments